Diminished responsiveness of G(s)-coupled receptors in severely failing human hearts: No difference in dilated versus ischemic cardiomyopathy

Journal of Cardiovascular Pharmacology

Volumn 31, Issue 4, 1998, Pages 585-594

  Brodde, Otto Erich ^a,b   Vogelsang, Magdalene ^a   Broede, Andrea ^a   Michel Reher, Martina ^a   Beisenbusch Schäfer, Ellen ^a   Hakim, Kavous ^a   Zerkowski, Hans Reinhard ^a  

^a UNIVERSITY OF DUISBURG ESSEN   (Germany)

^b MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Adenylyl cyclase; Dilated cardiomyopathy; G proteins; Ischemic cardiomyopathy; Adrenoceptors

Indexed keywords

3 ISOPROPYLAMINO 1 (7 METHYL 4 INDANYLOXY) 2 BUTANOL; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; ADENYLATE CYCLASE; ADRENALIN; BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYANOPINDOLOL I 125; DOBUTAMINE; DOPAMINE; EPININE; FLUORIDE SODIUM; GUANOSINE TRIPHOSPHATE; HISTAMINE; INHIBITORY GUANINE NUCLEOTIDE BINDING PROTEIN; ISOPRENALINE; MANGANESE; NORADRENALIN; SEROTONIN; STIMULATORY GUANINE NUCLEOTIDE BINDING PROTEIN; TERBUTALINE; CYANOIODOPINDOLOL; DRUG DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN; PINDOLOL;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HEART ATRIUM; HEART DILATATION; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLE; HEART VENTRICLE CONTRACTILITY; HUMAN; HUMAN TISSUE; INOTROPISM; ISCHEMIC HEART DISEASE; MALE; ORGAN DONOR; PRIORITY JOURNAL; CONGESTIVE CARDIOMYOPATHY; DONOR; DRUG EFFECT; HEART CONTRACTION; HEART MUSCLE ISCHEMIA; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY;

ADENYLATE CYCLASE; ADRENERGIC BETA-AGONISTS; ADULT; CARDIOMYOPATHY, DILATED; FEMALE; GTP-BINDING PROTEINS; GUANOSINE TRIPHOSPHATE; HEART ATRIA; HEART TRANSPLANTATION; HEART VENTRICLES; HISTAMINE; HUMANS; IODOCYANOPINDOLOL; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; MYOCARDIAL ISCHEMIA; PINDOLOL; RECEPTORS, ADRENERGIC, BETA; SEROTONIN; TISSUE DONORS;

EID: 0031596581     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199804000-00018     Document Type: Article

References (56)

1. Bristow MR, Ginsburg R, Minobe W, et al. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 1982;307:205-11.
2. Brodde O-E, Michel MC, Zerkowski H-R. Signal transduction mechanisms controlling cardiac contractility and their alterations in chronic heart failure. Cardiovasc Res 1995;30:570-84.
3. 2-adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 1991;43:203-42.
4. 2-adrenoceptor function related to the degree of heart failure in patients with mitral valve disease. J Am Coll Cardiol 1989;14:323-31.
5. 2-adrenoceptors in different human heart diseases. Naunyn Schmiedebergs Arch Pharmacol 1991;343:217-20.
6. Schumacher C, Becker H, Conrads R, et al. Hypertrophic cardiomyopathy: a desensitized cardiac β-adrenergic system in the presence of normal plasma catecholamine concentrations. Naunyn Schmiedebergs Arch Pharmacol 1995;351:398-407.
7. 2-adrenoceptors. Eur Heart J 1989;10(suppl B):38-44.
8. 2-adrenoceptors in the failing and nonfailing human hearts. Eur J Clin Pharmacol 1992;42:607-12.
9. Bristow MR, Anderson FL, Port JD, et al. Differences in β-adrenergic neuroeffeclor mechanisms in ischemic versus idiopathic dilated cardiomyopathy. Circulation 1991;84:1024-39.
10. 1-adrenergic receptors in the failing human heart. Circulation 1993;87:454-63.
11. Feldman AM. Experimental issues in assessment of G protein function in cardiac disease. Circulation 1991;84:1852-61.
12. Eschenhagen T. G Proteins and the heart. Cell Biol Int 1993;17: 723-49.
13. 1-receptor downregulation in heart failure. Circ Res 1986;59:297-309.
14. 2-adrenoceptor-mediated positive inotropic effects in human end-stage heart failure. Br J Pharmacol 1992;105:463-9.
15. 2-receptor agonist impromidine in human myocardium from patients with heart failure due to mitral and aortic valve disease. J Cardiovasc Pharmacol 1983;5:618-25.
16. Näbauer M, Böhm M, Brown L, et al. Positive inotropic effects in isolated ventricular myocardium from non-failing and terminally failing human hearts. Eur J Clin Invest 1988;18:600-6.
17. Erdmann E. The effectiveness of inotropic agents in isolated cardiac preparations from the human heart. Klin Wochenschr 1988; 66:1-6.
18. Pitschner HF, Droege A, Mitze M, Schlepper M, Brodde O-E. Downregulaled β-adrenoceptors in severely failing human ventricles: uniform regional distribution, but no increased internalization! Bas Res Cardiol 1993;88:179-91.
19. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-54.
20. Brodde O-E, Zerkowski H-R, Schranz D, et al. Age-dependent changes of the β-adrenoceptor-G-protein(s)-adenylyl cyclase system in human right atrium. J Cardiovasc Pharmacol 1995;26:20-6.
21. 2-selective adrenoceptor antagonist (ICI 118, 551). J Cardiovasc Pharmacol 1983;5:430-7.
22. Salomon Y, Londos C, Rodbell M. A highly sensitive adenylate cyclase assay. Anal Biochem 1974;58:541-8.
23. Sternweis PC, Gilman AG. Reconstitution of catecholamine-sensitive adenylate cyclase: reconstitution of the uncoupled variant of the S49 lymphoma cell. J Biol Chem 1979;254:3333-40.
24. Michel MC, Brodde O-E, Insel PA. Are cardiac G-proteins altered in rat models of hypertension? J Hypertens 1993;11:353-63.
25. Burnette WN. "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate-polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A. Anal Biochem 1981;112:195-203.
26. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-5.
27. Motomura S, Zerkowski H-R, Daul A, Brodde O-E. On the physiologic role of beta-2 adrenoceptors in the human heart: in vitro and in vivo studies. Am Heart J 1990;119:608-19.
28. Deighton NM, Motomura S, Bals S, Zerkowski H-R, Brodde O-E. Characterization of the beta adrenoceptor subtype(s) mediating the positive inotropic effects of epinine, dopamine, dobutamine, denopamine and xamoterol in isolated human right atrium. J Pharmacol Exp Ther 1992;262:532-8.
29. Zerkowski H-R, Broede A, Kunde K, et al. Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human right atrium. Naunyn Schmiedebergs Arch Pharmacol 1993;347:347-52.
30. 1-adrenoceptor antagonist treatment. J Am Coll Cardiol 1994;23:1224-33.
31. Scatchard G. The attraction of proteins for small molecules and ions. Ann N Y Acad Sci 1949;51:660-72.
32. 2-adrenoceptors in the stimulation of adenylate cyclase and contractile force. Eur Heart J 1989;10(suppl B):29-37.
33. 2-adrenoceptors coupled to the adenylate cyclase in feline and human ventricle with positive inotropic effects. J Cardiovasc Pharmacol 1989;13:105-17.
34. Böhm M, Mittmann C, Schwinger RHG, Erdmann E. Effects of xamoterol on inotropic and lusitropic properties of the human myocardium and on adenylate cyclase. Am Heart J 1990;120:1381-92.
35. Denniss AR, Colucci WS, Allen PD, Marsh JD. Distribution and function of human ventricular beta adrenoceptors in congestive heart failure. J Mol Cell Cardiol 1989;21:651-60.
36. Lohse MJ. Molecular mechanisms of membrane receptor desensitization. Biochim Biophys Acta 1993;1179:171-88.
37. 1 receptor messenger RNA abundance in the failing human heart. J Clin Invest 1993;92:2737-45.
38. 1-adrenergic receptor mRNA in heart failure. J Am Coll Cardiol 1996;27:146-54.
39. 2-adrenergic receptors in human failing hearts: evaluation of the absolute cardiac mRNA levels by two independent methods. J Mol Cell Cardiol 1996;28:1-10.
40. 2-adrenoceptors in the human atrioventricular conducting system: a comparison of patients with idiopathic dilated cardiomyopathy and ischemic heart disease. J Mol Cell Cardiol 1994;26:313-23.
41. Engelhardt S, Zieger W, Kassubek J, Michel MC, Lohse MJ, Brodde O-E. Tocolytic therapy with fenoterol induces selective downregulation of β-adrenergic receptors in human myometrium. J Clin Endocrinol Metab 1997;82:1235-42.
42. Katada T, Northup JK, Bokoch GM, Ui M, Gilman AG. The inhibitory guanine nucleotide-binding regulatory component of adenylate cyclase: subunit dissociation and guanine nucleotide-dependent hormonal inhibition. J Biol Chem 1984;259:3578-85.
43. iα in human hearts with dilated but not ischemic cardiomyopathy. Circulation 1990;82:1249-65.
44. Feldman AM, Jackson DG, Bristow MR, Cates AE, van Dop C. Immunodetectable levels of the inhibitory guanine nucleotide binding regulatory proteins in failing human heart: discordance with measurements of adenylate cyclase activity and levels of pertussis toxin substrate. J Mol Cell Cardiol 1991;23:439-52.
45. 1-adrenoceptors. J Auton Pharmacol 1993;13:425-38.
46. Michel MC, Farke W, Erdbrügger W, Philipp T, Brodde O-E. Ontogenesis of sympathetic responsiveness in spontaneously hypertensive rats. II. Renal G proteins in male and female rats. Hypertension 1994;23:653-8.
47. Michel-Reher MB, Gross G, Jasper JJ, et al. Tissue- and subunit-specific regulation of G-protein expression by hypo- and hyperthyroidism. Biochem Pharmacol 1993;45:1417-23.
48. Strittmatter S, Neer EJ. Properties of the separated catalytic and regulatory units of brain adenylate cyclase. Proc Natl Acad Sci U S A 1980;77:6344-8.
49. Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ. A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol 1990;100:879-85.
50. 4-like receptor in human right atrium. Naunyn Schmiedebergs Arch Pharmacol 1991;344:150-9.
51. Jahnel U, Rupp J, Ertl R, Nawrath H. Positive inotropic response to 5-HT in human atrial but not in ventricular heart muscle. Naunyn Schmiedebergs Arch Pharmacol 1992;346:482-6.
52. Schoemaker RG, Du XY, Bax WA, Bos E, Saxena PR. 5-Hydroxytryptamine stimulates human isolated atrium but not ventricle. Eur J Pharmacol 1993;230:113-5.
53. 4-like receptor in human left atrium. Naunyn Schmiedebergs Arch Pharmacol 1992;345:382-6.
54. 1 adrenoceptors in transgenic mice. Cardiovasc Res 1993;27:1606-12.
55. 2-adrenergic receptor. Science 1994;264:582-6.
56. Kaumann AJ, Molenaar P. Modulation of human cardiac function through 4 β-adrenoceptor populations. Naunyn Schmiedebergs Arch Pharmacol 1997;355:667-81.